| http://www.w3.org/ns/prov#value | - The annual FDA/DIA Statistics Forum provides an open forum to discuss the statistical and regulatory implications of FDA initiatives and Guidances, explains Program Co-chair Barry Schwab, PhD, Vice President, Clinical Biostatistics, Johnson & Johnson Pharmaceutical Research and Development, LLC. Statisticians, clinicians and other industry, academia, CRO and agency personnel come together to sh
|
